Human Milk Oligosaccharides (HMO) Market research report by Delvens focuses on primary sections such as – market segments, market outlook, competitive landscape, and company profiles. The segments provide details in terms of various perspectives such as end-use industry, product or service type, and any other relevant segmentation as per the market’s current scenario which includes various aspects to perform further marketing activity. The market outlook section gives a detailed analysis of market evolution, growth drivers, restraints, opportunities, and challenges, Porter’s 5 Force’s Framework, macroeconomic analysis, value chain analysis and pricing analysis that directly shape the market at present and over the forecasted period.
The global Human Milk Oligosaccharides (HMO) Market size is projected to reach a CAGR of 23.4% from 2023-2030.
Get Free Sample Report: https://www.delvens.com/get-free-sample/human-milk-oligosaccharides-hmo-market
Human milk oligosaccharides, also known as human milk glycans, are short polymers of simple sugars that can be found in high concentrations exclusively in human breast milk. Human milk oligosaccharides promote the development of the immune system, can reduce pathogen infections, and improve brain development and cognition. Approximately 200 structurally different human milk oligosaccharides are known and the exact composting of these varies from mother to mother.
The functional benefits of these products have created a huge demand for the biosynthetic production of HMOs for use as additives in infant formulas and other dietary products. HMO molecules can be produced chemically, through fermentation, or through enzymatic synthesis. Moreover, the surge in demand for HMOs has increased the utilization of various nutritional products used as food or dietary supplements.
Key Findings
· The type segment is further segmented into 2’ FL, 3’ FL, 3’ SL, and 6’ SL. The 2’FL segment garnered the highest market share in 2022, as 2'-fucosyllactose (2’FL) is well-known for its ability to protect against infectious diseases by preventing toxins and pathogens from adhering to epithelial cells.
· Human milk oligosaccharides, also known as human milk glycans, are short polymers of simple sugars that can be found in high concentrations exclusively in human breast milk.
· Asia Pacific consisting of countries like China, India, Japan, Australia & New Zealand, and Others is found to dominate the HMO market with the presence of a large consumer base for HMO derivative products.
Competitive Landscape:
· Abbott Laboratories
· BASF S.E.
· Biosynth Carbosynth
· Chr. Hansen Holding A/S
· Dextra Laboratories Ltd.
· Dupont Nutrition & Biosciences
· Elicityl S.A.
· Glycom A/S
· Glycosyn
· Inbiose NV
· Medolac Laboratories
· Neolacta Lifesciences Pvt. Ltd
· Nestle Health Science
· Royal DSM
· ZuChem
For More Inquiry Contact us: https://www.delvens.com/Inquire-before-buying/human-milk-oligosaccharides-hmo-market
The Report helps to identify the opportunities in Global Regions:
· North America (the United States, Canada, and Mexico)
· Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
· Asia-Pacific (China, Japan, Korea, India, Australia, and Southeast Asia (Indonesia, Thailand, Philippines, Malaysia, and Vietnam))
· South America (Brazil etc.)
· The Middle East and Africa (North Africa and GCC Countries)
Recent Developments
In August 2021, nestle launched the new NAN SUPREME PRO 3 formula products with five human milk oligosaccharides (2’-FL, DFL, LNT, 3’-SL, and 6’-SL), which it claims enhance children’s immunity systems.
In September 2020, Chr. Hansen acquired Jennewein Biotechnologies GmbH and a strong patent portfolio relating to the production of human milk oligosaccharides (HMOs) and several litigations related hereto.
Reasons to Acquire
· Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors.
· Gain authentic and granular data access for Human Milk Oligosaccharides (HMO) Market so as to understand the trends and the factors involved behind changing market situations.
· Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.
· In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns.
Access Full Report: https://www.delvens.com/report/human-milk-oligosaccharides-hmo-market
In addition to the market data for Human Milk Oligosaccharides (HMO) Market, Delvens offers client-centric reports customized according to the company’s specific demand and requirement.
More Reports From Delvens:
Dairy Products market size was estimated at USD 517.40 billion in 2023 and is projected to reach USD 684.54 billion in 2030 at a CAGR of 4.08% during the forecast period 2023-2030.
Shrimp Feed market size was estimated at USD 9.96 billion in 2023 and is projected to reach USD 14.35 billion in 2030 at a CAGR of 5.36% during the forecast period 2023-2030.
Lactase market size was estimated at USD 271.8 billion in 2023 and is projected to reach USD 406.06 billion in 2030 at a CAGR of 5.90% during the forecast period 2023-2030.
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-3290-6466
+1 214-377-1144
